BTTX (Better Therapeutics) Other Financing: $6.14 Mil (TTM As of Sep. 2023)


What is Better Therapeutics Other Financing?

Better Therapeutics BTTX Other Financing is $6.14 Mil as of Sep. 2023.

Better Therapeutics's Other Financing for the three months ended in Sep. 2023 was $0.00 Mil.

Better Therapeutics's Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 was $6.14 Mil.

Better Therapeutics Other Financing Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Other Financing Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Financing
0.00 0.00 43.66 0.28

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 6.14 0.00

Better Therapeutics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $6.14 Mil mean?
Better Therapeutics (BTTX) has a Other Financing of $6.14 Mil as of Sep. 2023. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Better Therapeutics and its competitors.
Is Better Therapeutics' Other Financing too high?
Better Therapeutics' current Other Financing is $6.14 Mil.
How does Better Therapeutics' Other Financing compare to CYCN and CELZ?
Better Therapeutics' Other Financing of $6.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Better Therapeutics and its competitors. Better Therapeutics's current Other Financing is $6.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Other Financing of $6.14 Mil. The current Other Financing is $6.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Other Financing is $6.14 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.